Trevi Therapeutics, Inc. (TRVI) NASDAQ
15.27
+0.51(+3.46%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
15.27
+0.51(+3.46%)
Currency In USD
| Market Cap | 1.82B |
| Enterprise Value | 1.8B |
| P/E Ratio | -48.74 |
| PEG Ratio | -1.37 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 12.92 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -45.46 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.25 |
| Return On Equity | -0.25 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -42.68M |
| Net Income | -42.76M |
| Diluted EPS | -0.29 |
| Total Cash | 171.78M |
| Total Cash/Share | 1.18 |
| Total Debt | 682,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 24.75 |
| Book Value Per Share | 1.18 |
| 52-Week Change | 146.69 |
| 52-Week High | 16.12 |
| 52-Week Low | 5.38 |
| Moving Average 50 Days | 13.01 |
| Moving Average 200 Days | 10.97 |
| Average Volume | 1.53M |
| Shares Outstanding | 141.98M |
| % Held by Institutions | 89.8 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |